Human Genome Epidemiology Literature Finder
Records 1 - 23 (of 23 Records) |
Query Trace: Obesity and FAAH[original query] |
---|
Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH). International journal of obesity (2005) 2005 Jul 29 (7): 755-9. Sipe J C, Waalen J, Gerber A, Beutler |
Genetic variation in two proteins of the endocannabinoid system and their influence on body mass index and metabolism under low fat diet. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2007 May 39 (5): 395-7. Aberle J, Fedderwitz I, Klages N, George E, Beil F |
The functional Pro129Thr variant of the FAAH gene is not associated with various fat accumulation phenotypes in a population-based cohort of 5,801 whites. Journal of molecular medicine (Berlin, Germany) 2007 May 85 (5): 445-9. Jensen Dorit P, Andreasen Camilla H, Andersen Mette K, Hansen Lars, Eiberg Hans, Borch-Johnsen Knut, Jørgensen Torben, Hansen Torben, Pedersen Ol |
The fatty acid amide hydrolase (FAAH) Pro129Thr polymorphism is not associated with severe obesity in Greek subjects. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2008 Dec 40 (12): 907-10. Papazoglou D, Panagopoulos I, Papanas N, Gioka T, Papadopoulos T, Papathanasiou P, Kaitozis O, Papatheodorou K, Maltezos |
The cDNA 385C to A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) is associated with overweight/obesity but not with binge eating disorder in overweight/obese women. Psychoneuroendocrinology 2008 May 33 (4): 546-50. Monteleone Palmiero, Tortorella Alfonso, Martiadis Vassilis, Di Filippo Carmela, Canestrelli Benedetta, Maj Mar |
Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. Biological psychiatry 2009 Jul 66 (1): 9-16. Hariri Ahmad R, Gorka Adam, Hyde Luke W, Kimak Mark, Halder Indrani, Ducci Francesca, Ferrell Robert E, Goldman David, Manuck Stephen |
Effects of C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase on weight loss after a hypocaloric diet. Metabolism: clinical and experimental 2011 May 60 (5): 730-4. de Luis Daniel Antonio, Gonzalez Sagrado Manuel, Aller Rocio, Izaola Olatz, Conde Ro |
[C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and adipocytokine levels in the morbidly obese]. Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición 2010 Feb 57 (2): 54-9. De Luis Daniel A, González Sagrado Manuel, Aller Rocío, Izaola Olatz, Conde Rosa, Romero Enriq |
Population sequencing of two endocannabinoid metabolic genes identifies rare and common regulatory variants associated with extreme obesity and metabolite level. Genome biology 2010 Nov 11 (11): 11. Harismendy O, Bansal V, Bhatia G, Nakano M, Scott M, Wang XC, Dib C, Turlotte E, Sipe JC, Murray SS, Deleuze JF, Bafna V, Topol EJ, Frazer KA |
C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance in patients with diabetes mellitus type 2. Diabetes research and clinical practice 2010 Apr 88 (1): 76-80. de Luis D A, Sagrado M Gonzalez, Aller R, Izaola O, Conde R, Romero |
Mutation screen and association studies for the fatty acid amide hydrolase (FAAH) gene and early onset and adult obesity. BMC medical genetics 2010 Jan 11 (1): 1. Müller Timo D, Brönner Günter, Wandolski Melanie, Carrie Jophia, Nguyen Trang T, Greene Brandon H, Scherag André, Grallert Harald, Vogel Carla Ig, Scherag Susann, Rief Winfried, Wichmann Hans-Erich, Illig Thomas, Schäfer Helmut, Hebebrand Johannes, Hinney An |
Biomarkers of endocannabinoid system activation in severe obesity. PloS one 2010 5 (1): e8792. Sipe Jack C, Scott T Michael, Murray Sarah, Harismendy Olivier, Simon Gabriel M, Cravatt Benjamin F, Waalen Ji |
C358A missense polymorphism of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) and visfatin levels in obese females. International journal of obesity (2005) 2010 Mar 34 (3): 511-5. de Luis D A, Gonzalez Sagrado M, Aller R, Izaola O, Conde R, Romero |
Relation of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) with obesity and insulin resistance. Nutrición hospitalaria 0 25 (6): 993-8. de Luis D A, González Sagrado M, Aller R, Izaola O, Conde |
Association of genetic variation in cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 2011 Jul 23 (7): 637-e257. Vazquez-Roque M I, Camilleri M, Vella A, Carlson P, Laugen J, Zinsmeister A |
Relationship among metabolic syndrome, C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and insulin resistance. Journal of diabetes and its complications 0 26 (4): 328-32. de Luis D A, Aller R, Izaola O, Conde R, Sagrado M Gonzalez, Primo D, Castro M |
Effects of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) on weight loss, adipocytokines levels, and insulin resistance after a high polyunsaturated fat diet in obese patients. Journal of endocrinological investigation 2013 Dec 36 (11): 965-9. de Luis D A, Izaola O, Aller R, de La Fuente B, Pacheco |
Circulating Endocannabinoids and the Polymorphism 385C>A in Fatty Acid Amide Hydrolase (FAAH) Gene May Identify the Obesity Phenotype Related to Cardiometabolic Risk: A Study Conducted in a Brazilian Population of Complex Interethnic Admixture. PloS one 2015 10 (11): e0142728. Martins Cyro José de Moraes, Genelhu Virginia, Pimentel Marcia Mattos Gonçalves, Celoria Bruno Miguel Jorge, Mangia Rogerio Fabris, Aveta Teresa, Silvestri Cristoforo, Di Marzo Vincenzo, Francischetti Emilio Anton |
Genetic polymorphisms of the endocannabinoid system in obesity and diabetes. Diabetes, obesity & metabolism 2018 8 21 (2): 382-387. Doris Joseph M, Millar Sophie A, Idris Iskandar, O'Sullivan Saoirse |
The influence of the fatty acid amide hydrolase 385C>A single nucleotide polymorphisms on obesity susceptibility. Molecular biology reports 2019 Jul . Yagin Neda Lotfi, Aliasgari Fereshteh, Aliasgharzadeh Soghra, Mahdavi Reza, Akbarzadeh Mary |
D3 dopamine receptors and a missense mutation of fatty acid amide hydrolase linked in mouse and men: implication for addiction. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2019 11 45 (5): 745-752. Mansouri Esmaeil, Nobrega José N, Hill Matthew N, Tyndale Rachel F, Lee Francis S, Hendershot Christian S, Best Laura M, Di Ciano Patricia, Balsevich Georgia, Sloan Mathew E, Kish Stephen J, Tong Junchao, Le Foll Bernard, Boileau Isabel |
Racial and sex differences in the polymorphisms of the endocannabinoid receptor genes in obesity. Journal of diabetes and its complications 2020 Jul 107682. Thethi Tina K, Sigel Aster, Japa Shanker, Katalenich Bonnie, Liu Shuqian, Nguyen Tuyen, Larrazolo Joshua, Syu Stephanie, Carefoot Esther, McDuffie Roberta, Fonseca Vivi |
FAAH Pro129Thr Variant Is Associated with Increased Cholesterol Levels in Normal-Weight Metabolically Unhealthy Subjects. Metabolic syndrome and related disorders 2023 7 . Erika Sierra-Ruelas, Nathaly Torres-Castillo, Barbara Vizmanos, Wendy Campos-Pérez, Oscar David Lopez-Cortes, Vincenzo Di Marzo, Erika Martínez-Lóp |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: